Literature DB >> 18326165

Diagnosis and treatment of testicular cancer.

Joel Shaw1.   

Abstract

Testicular cancer is the most common malignancy in men 20 to 35 years of age and has an annual incidence of four per 100,000. If diagnosed early, the cure rate is nearly 99 percent. Risk factors for testicular cancer include cryptorchidism (i.e., undescended testicles), family history, infertility, tobacco use, and white race. Routine self-examination and physician screening have not been shown to improve outcomes, and the U.S. Preventive Services Task Force and American Cancer Society do not recommend them in asymptomatic men. Patients presenting with a painless testicular mass, scrotal heaviness, a dull ache, or acute pain should receive a thorough examination. Testicular masses should be examined with scrotal ultrasonography. If ultrasonography shows an intratesticular mass, the patient should be referred to a urologist for definitive diagnosis, orchiectomy, and further evaluation with abdominal computed tomography and chest radiography. The family physician's role after diagnosis of testicular cancer includes encouraging the patient to bank sperm because of possible infertility and evaluating for recurrence and future complications, especially cardiovascular disease.

Entities:  

Mesh:

Year:  2008        PMID: 18326165

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  11 in total

1.  Evaluation of germ-cell neoplasia in situ entity in testicular tumors.

Authors:  Mehmet Akyüz; Ramazan Topaktaş; Ahmet Ürkmez; Orhan Koca; Metin İshak Öztürk
Journal:  Turk J Urol       Date:  2018-03-16

2.  Sonographic classification of testicular tumors by tissue harmonic imaging: experience of 58 cases.

Authors:  Atsuo Kawamoto; Tadashi Hatano; Kazuhiro Saito; Rie Inoue; Toshitaka Nagao; Shigeru Sanada
Journal:  J Med Ultrason (2001)       Date:  2017-03-20       Impact factor: 1.314

3.  Mental Health in Urologic Oncology.

Authors:  Danyon Anderson; Abrahim N Razzak; Matthew McDonald; David Cao; Jamal Hasoon; Omar Viswanath; Alan D Kaye; Ivan Urits
Journal:  Health Psychol Res       Date:  2022-08-20

4.  Prognostic features and markers for testicular cancer management.

Authors:  Eddy S Leman; Mark L Gonzalgo
Journal:  Indian J Urol       Date:  2010 Jan-Mar

5.  Massive seminoma presenting with inguinal lymph node metastases only.

Authors:  Benjamin C Norton; Ian Robertson; Hui Fan; Rula Najim; Yaman Altal; Ann Sandison; David Hrouda
Journal:  J Surg Case Rep       Date:  2016-11-24

Review 6.  Testicular cancer from diagnosis to epigenetic factors.

Authors:  Mariarosaria Boccellino; Daniela Vanacore; Silvia Zappavigna; Carla Cavaliere; Sabrina Rossetti; Carmine D'Aniello; Paolo Chieffi; Evzen Amler; Carlo Buonerba; Giuseppe Di Lorenzo; Rossella Di Franco; Alessandro Izzo; Raffaele Piscitelli; Gelsomina Iovane; Paolo Muto; Gerardo Botti; Sisto Perdonà; Michele Caraglia; Gaetano Facchini
Journal:  Oncotarget       Date:  2017-09-18

7.  The systematic analysis and 10-year prediction on disease burden of childhood cancer in China.

Authors:  Bo Zhu; Xiaomei Wu; Wenxiu An; Bing Yao; Yefu Liu
Journal:  Front Public Health       Date:  2022-09-06

8.  Renal Cell Carcinoma with Testicular Metastases: A Case Report and Review of the Literature.

Authors:  Sho Yoshitake; Brian M Shinder; Kevin Dazen; Colton Smith; Tina M Mayer; Evita Sadimin; Eric A Singer
Journal:  J Kidney Cancer VHL       Date:  2022-05-06

9.  Recurrence of acute myeloid leukemia in cryptorchid testis: case report.

Authors:  Luccas Santos Patto de Góes; Roberto Iglesias Lopes; Octavio Henrique Arcos Campos; Luiz Carlos Neves de Oliveira; Alexandre Crippa Sant'Anna; Marcos Francisco Dall'Oglio; Miguel Srougi
Journal:  Einstein (Sao Paulo)       Date:  2014 Jan-Mar

10.  Escalation of an Otherwise Curable Cancer: Retroperitoneal Mass Destruction Associated With Testicular Seminoma in a Psychiatric Patient.

Authors:  Krishna Teja Challa; Megan LeBlanc; Habtemariam Makonnen
Journal:  Cureus       Date:  2020-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.